In the speech, Trump criticized drug industry lobbying while the health secretary suggested drug companies disclose prices in ads
Drug policy experts and price advocates on Friday panned a long-overdue speech by Donald Trump on drug prices.
As part of the speech, the US health secretary, Alex Azar, suggested drug companies should be required to disclose pharmaceutical prices in advertisements as an incentive to set lower prices.
Continue reading...from US news | The Guardian https://ift.tt/2jUoBa5
0 comments:
Post a Comment